7[4]Hjelstuen A,Anderssen SA,Holme I,et al.Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives[J].Scand Cardiovasc J,2007,41(5):313-320.
8[5]Virani SS,Nambi V.The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis[J].Curt Atheroscler Rep,2007,9(2):97-103.
9[6]Santiili F,Bucciarelli L,Noto D,et al.Decreased plasma soluble RAGE in patients with hypercholesterolemia:effects of statins[J].Free Radie Biol Med,2007,43(9):1255-1262.
10[7]Vogt A,Kassner U,Hostalek U,et al.Correction of low HDL cholesterol to reduce cardiovascular risk:practical considerations relating to the therapeutic use of prolonged-release nicotinic acid (Niaspan)[J].Int J Chn Pract,2007,61(11):1914-1921.
